TheEdgeResearch
Home / Stocks / JRSS

JRSIS Health Care Corporation (JRSS)

OTC Healthcare Medical - Care Facilities
$0.02 ▲ +0.00%
Market Cap
$1.5M
Sector
Healthcare
Industry
Medical - Care Facilities
Beta
0.68
52-Wk Range
0.0058-0.2
CEO
Linhai Zhu
Country
CN
Currency
USD

JRSIS Health Care Corporation operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Yongzhou, HU, CN. The stock last traded at $0.02, up 0.00% on the session, giving a market capitalisation of $1.5M. On trailing twelve-month figures it carries a trailing P/E of -9.47, a net margin of -3.7%. Its beta of 0.68 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-9.47
Price / Sales
6.74
Price / Book
-15.75
EV / EBITDA
-326.91
Gross margin
16.0%
Operating margin
-3.9%
Net margin
-3.7%
Return on equity
Debt / equity
0.00
Current ratio
0.32
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
36
IPO date
2016-09-27
Headquarters
Yongzhou, HU, CN
About JRSIS Health Care Corporation

Established in 2006, JRSIS Health Care Corporation, originally named China Runteng Medical Group Co., Ltd until its rebranding in November 2013, operates from Harbin in China's Heilongjiang Province. The corporation specializes in delivering a broad spectrum of medical services. These include pediatrics, dermatology, otolaryngology (ears, nose, and throat), traditional Chinese medicine, ophthalmology, internal medicine, dentistry, general surgery, rehabilitation sciences, and gynecology, alongside various general healthcare provisions. JRSIS facilitates these services primarily through Jiarun Hospital, a substantial medical facility equipped with 950 patient beds.

Comparable companies

JRSIS Health Care Corporation is most often compared with the following Healthcare names:

BIEICAFSDYNTITNSKJFIMSMYNEWUFSCRSFSTMHTRLFF
More research on JRSS
JRSS technical analysis JRSS TheEdge Score Compare against peers
Open full interactive analysis & DCF →